Literature DB >> 10976260

Drug-resistant tuberculosis.

R Long1.   

Abstract

Globally the proportion of tuberculosis cases caused by drug-resistant strains is increasing. Interruptions in the drug supply, improper drug prescription and nonadherence to treatment protocols promote drug resistance through mechanisms that are now well understood. The treatment of tuberculosis must take into account the possibility of drug resistance and include at least 2 drugs, preferably 3, to which the isolate is proven or anticipated to be susceptible.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10976260      PMCID: PMC80378     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  24 in total

1.  Classification of drug-resistant tuberculosis in an epidemic area.

Authors:  A Van Rie; R Warren; M Richardson; R P Gie; D A Enarson; N Beyers; P D Van Helden
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

2.  'Pseudo' treatment failure of pulmonary tuberculosis in association with a tuberculoma.

Authors:  R Long; S Chomyc; E Der; D S Sitar
Journal:  Can Respir J       Date:  2000 Jan-Feb       Impact factor: 2.409

3.  Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.

Authors:  D A Mitchison; A J Nunn
Journal:  Am Rev Respir Dis       Date:  1986-03

4.  Spectrum of tuberculosis in patients with HIV infection in British Columbia: report of 40 cases.

Authors:  M Korzeniewska-Kosela; J M FitzGerald; S Vedal; E A Allen; M T Schechter; L Lawson; P Phillips; W Black; J S Montaner
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

Review 5.  Drug-resistant tuberculosis.

Authors:  M D Iseman; L A Madsen
Journal:  Clin Chest Med       Date:  1989-09       Impact factor: 2.878

Review 6.  Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review.

Authors:  M Zierski
Journal:  Lung       Date:  1977       Impact factor: 2.584

7.  A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.

Authors: 
Journal:  Tubercle       Date:  1974-03

8.  Multidrug-resistant tuberculosis in Alberta and British Columbia, 1989 to 1998.

Authors:  A Hersi; K Elwood; R Cowie; D Kunimoto; R Long
Journal:  Can Respir J       Date:  1999 Mar-Apr       Impact factor: 2.409

9.  Drug-resistant tuberculosis in a southern California hospital. Trends from 1969 to 1984.

Authors:  I Ben-Dov; G R Mason
Journal:  Am Rev Respir Dis       Date:  1987-06

10.  Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1979-04
View more
  11 in total

1.  A clinical approach to paediatric tuberculosis in Canada.

Authors:  Ian Kitai; Patricia Malloy
Journal:  Paediatr Child Health       Date:  2003-03       Impact factor: 2.253

2.  Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation.

Authors:  Ashok Dongamanti; Vikas Kumar Aamate; Mohan Gandhi Devulapally; Srinivas Gundu; Saikrishna Balabadra; Vijjulatha Manga; Perumal Yogeeswari; Dharmarajan Sriram; Sridhar Balasubramanian
Journal:  Mol Divers       Date:  2017-08-24       Impact factor: 2.943

3.  Conventional and microwave-assisted synthesis of new indole-tethered benzimidazole-based 1,2,3-triazoles and evaluation of their antimycobacterial, antioxidant and antimicrobial activities.

Authors:  Dongamanti Ashok; Srinivas Gundu; Vikas Kumar Aamate; Mohan Gandhi Devulapally
Journal:  Mol Divers       Date:  2018-04-18       Impact factor: 2.943

4.  Molecular characteristics of rifampin- and isoniazid-resistant mycobacterium tuberculosis strains isolated in Vietnam.

Authors:  Nghiem Ngoc Minh; Nguyen Van Bac; Nguyen Thai Son; Vu Thi Kim Lien; Chu Hoang Ha; Nguyen Huu Cuong; Cung Thi Ngoc Mai; Thanh Hoa Le
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

5.  Infection control and paediatric tuberculosis: A practical guide for the practicing paediatrician.

Authors:  Anne Matlow; Maryanne Robb; Carol Goldman
Journal:  Paediatr Child Health       Date:  2003-12       Impact factor: 2.253

6.  Population-based molecular epidemiological study of tuberculosis in Malatya, Turkey.

Authors:  Riza Durmaz; Thierry Zozio; Selami Gunal; Caroline Allix; Maryse Fauville-Dufaux; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2007-10-10       Impact factor: 5.948

7.  Tuberculosis in adolescents and young patients in high prevalence region.

Authors:  T Avdeeva; I Otvagin; T Myakisheva; E Rashkevich
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-12-11

8.  Radiological signs associated with pulmonary multi-drug resistant tuberculosis: an analysis of published evidences.

Authors:  Yì Xiáng J Wáng; Myung Jin Chung; Aliaksandr Skrahin; Alex Rosenthal; Andrei Gabrielian; Michael Tartakovsky
Journal:  Quant Imaging Med Surg       Date:  2018-03

9.  Demographic and microbial characteristics of extrapulmonary tuberculosis cases diagnosed in Malatya, Turkey, 2001-2007.

Authors:  Selami Gunal; Zhenhua Yang; Mansi Agarwal; Mehmet Koroglu; Zeynep Kazgan Arıcı; Riza Durmaz
Journal:  BMC Public Health       Date:  2011-03-08       Impact factor: 3.295

10.  Disaccharide analogs as probes for glycosyltransferases in Mycobacterium tuberculosis.

Authors:  Ashish K Pathak; Vibha Pathak; Lainne Seitz; Sudagar S Gurcha; Gurdyal S Besra; James M Riordan; Robert C Reynolds
Journal:  Bioorg Med Chem       Date:  2007-04-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.